Kpodonu, J., Massad, M.G., Chaer, R.A., et al. (2005) The US Experience with Lung Transplantation for Pulmonary Lymphangioleyomiomatosis. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, 24, 1247-1253.
http://dx.doi.org/10.1016/j.healun.2004.09.013

has been cited by the following article:

• TITLE: Successful Tacrolimus Therapy Extended by Everolimus in Retroperitoneal Angiomyolipoma after Lung Transplantation: A Case Report

  AUTHORS: Tamás Erdélyi, Anikó Bohács, Krisztina Vincze, Zsuzsanna Kováts, Veronika Sárosi, András Sinkovicz, György Balázs, Veronika Müller

  KEYWORDS: Lymphangioleiomyomatosis, Everolimus, Angiomyolipoma, Lung Transplant

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.3 No.12, December 8, 2014

  ABSTRACT: Lymphangioleiomyomatosis (LAM) is a rare disease that affects women, especially in child-bearing age. Clinical manifestations include angiomyolipoma, pneumothorax, chylothorax, cystic changes of lungs and progressive pulmonary failure. In this article, we report a case of lung transplantation (LuTX) for end stage pulmonary LAM and the treatment of angiomyolipoma showing growth after LuTX resulting in complete remission with combination therapy of everolimus and tacrolimus.